Are you Dr. Torres?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 38 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Harrys Torres, MD is an infectious disease specialist in Houston, Texas. He is currently licensed to practice medicine in Texas, Washington, and Tennessee. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2007 - 2009
- University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2005 - 2007
Certifications & Licensure
- FL State Medical License 2021 - Present
- WA State Medical License 2023 - 2026
- TN State Medical License 2023 - 2025
- TX State Medical License 2009 - 2025
- GA State Medical License 2023 - 2025
- AZ State Medical License 2023 - 2025
- OK State Medical License 2020 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- Join now to see all
Clinical Trials
- Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC) Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center.Khalis Mustafayev, Ruston P Juneau, Georgios Angelidakis, Ernest Hawk, Harrys A Torres, Jessica P Hwang, Lan Sun Wang, Bruno P Granwehr, Eduardo Yepez Guevara, Anita K...> ;Journal of the National Comprehensive Cancer Network. 2024 May 10
- Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors.Khalis Mustafayev, Vincent Mallet, Harrys A Torres> ;Journal of Immunotherapy and Precision Oncology. 2024 May 1
- Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma.Khalis Mustafayev, Harrys A Torres, Loretta J Nastoupil, Samuel A Shelburne> ;Lancet. 2024 Apr 6
- Join now to see all
Press Mentions
- Treating HCV in Cancer Patients Opens Chemotherapy OptionsMarch 14th, 2019
- Best of Cancerwise 2018: Helpful Insights from Our ExpertsDecember 19th, 2018
- Lymphoma Survivor: Why I Recommend Hepatitis C TestingJune 28th, 2018
- Join now to see all
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas